JAZZ vs OLN · P/E 1988, rev $4.07B vs rev $6.54B
Jazz Pharmaceuticals PLC (JAZZ) versus Olin Corporation (OLN) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Olin Corporation (OLN) is a chemicals company listed on NYSE.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported OLN revenue for 2024-12-31 was $6.54B. Net income was $105.0M. Revenue was down 4.3% from 2023-12-31 to 2024-12-31. OLN currently screens at market cap $2.62B.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. OLN currently screens at market cap $2.62B.
Not investment advice. Open the JAZZ and OLN stock pages for the full models.
Not investment advice.